Industry Reports Services Press Release
  •   Blogs
  • Contact us About us

    Asia Pacific Biodefense Market Forecast 2028 By Product (Vaccines {Anthrax, Smallpox, Botulism}, Biothreat Detection Devices {Samplers, Detectors/Triggering Devices, Identifiers, Assays and Reagents}), Research Report, Country Outlook (Japan, China, India, Australia), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share
    Published Date: May 2022   |   Report ID: GR2111   |   Delivery: PDF  Request Free Sample

    Asia Pacific Biodefense Market size valued at USD 2.9 billion in 2021 and is projected to observe around 8.9% growth rate between 2022 and 2028.

    Rising tension between nations across the globe, is one of the key factors driving the market growth. Similarly, increased defense spending by governments of several Asia Pacific countries to improve internal and external security is also propelling the market expansion.

    Get more details on this report - Request Free Sample PDF

    Innovative technologies such as gene chips for detecting pathogens are widely used in the biodefense-related nanotechnology, forensic medicine, and drug development. Government agencies identify various chemical, biological, nuclear, and radioactive threats and develop medical measures to minimize the adverse effects of these attacks. Apart from that, there is growing awareness of synthetic biology to improve agricultural yields, also has a positive impact on the market revenue.


     Asia Pacific Market, By Product

    Get more details on this report - Request Free Sample PDF

    The vaccines segment in the Asia Pacific biodefense market will exhibit a CAGR of 9% during the forecast period. The segmental growth is high as researchers are investigating new vaccine technologies, such as vector technology that guides rapid protection against pathogen attacks. These vaccines can target a wide range of biological agents and elicit a long-term immune response after a single oral dose. Further, many companies are competing for vaccine development due to the increase in Ebola virus, Zika virus, infections in some countries.

     Asia Pacific Market, By Country

    China biodefense market revenue was over USD 800 million in 2021 and will grow at 9% CAGR through 2028. Factor such as the rising prevalence of infectious diseases, awareness about the availability of vaccines will augment the market expansion. Additionally, over the years, the country has researched potential biological warfare agents such as the causative agents of encephalitis, Q fever, plague, anthrax, tularemia, and psittacosis. The country possesses the technology to mass-produce most these traditional biological warfare agents.

    Moreover, many players are using advanced technology to launch innovative bio-threat detection devices that help efficiently identify multiple viruses and bacteria. The market is further driven by the increasing demand for effective medical interventions and threat detection devices due to the rapid outbreak of the COVID 19 pandemic.


     Competitive Industry Landscape

    Prominent players operating in the Asia Pacific biodefense market include Smiths Detection Group Ltd., Bavarian Nordic, Biosearch Technologies, Alexeter Technologies LLC, Bruker Detection, Electronic Sensor Technology Inc., Dynavax Technologies, Emergent BioSolutions, BioFire Defense (bioMérieux SA), Ichor Medical Systems, Inc., and Nanologix.

    These companies have adopted various strategies such as product launches, collaborations, distribution agreements, and acquisitions that have helped them in sustaining the competition and gain significant position in the market.

    Frequently Asked Question(FAQ) :

    What is the size of the Asia Pacific biodefense market?
    The industry for biodefense in the Asia Pacific generated over USD 2.9 billion in 2021 and is poised to observe a growth rate of over 8.9% between 2022 and 2028 on account of the augmented defense spending by governments in several countries for improved internal and external security.
    How are vaccines contributing to the Asia Pacific biodefense sector?
    The market revenue for biodefense in Asia Pacific from the vaccine product segment is likely to strike a CAGR of over 9% through 2028 owing to the rising investigations in new vaccine technologies, including vector technology to offer rapid protection against pathogen attacks.
    How much is the biodefense industry worth in China?
    The industry share for biodefense in China was valued at more than USD 800 million in 2021 and is likely to record a 9% CAGR through 2028 on account of the higher prevalence of infectious diseases, and the growing awareness about the availability of vaccines in the country.
    Which are the leading biodefense companies in APAC?
    Smith’s Detection Group Ltd., Biosearch Technologies, Alexeter Technologies LLC, Bruker Detection, Electronic Sensor Technology Inc., Emergent BioSolutions, BioFire Defense, Ichor Medical Systems, Inc., and Nanologix are some well-known the industry players in the region.

    Get this research report on Asia Pacific Biodefense Market customized according to your business requirements.

    report-purchase - logo Buy Now

    Why Choose us?

    • on-time delivery On-Time Delivery

      We commit to on-time delivery of reports to keep you ahead.

    • assured quality Assured Quility

      With a wide network of industry experts and trained in-house analysts, we assure best service quality.

    • Custom Research Service

      We offer research services to meet specific client requirements and provide them with actionable insights on target markets.

    • payment security Payment Security

      Our safe payment gateway gives you full control of your personal data, at all times.

    Connect with our sales team


     [email protected]